Governance - LyonbiopôleLyonbiopôle, pôle de compétitivité mondial en santé

Lyonbiopole Governance

Headlines

IXALTIS announces successful completion of phase 2 for its compound Litoxtine

May 15^th, 2019

ERYTECH announces FDA’s authorization to proceed with phase 3 trial for Eryaspase in pancreatic cancer

May 15^th, 2019

VALBIOTIS will present the results of the international Phase IIA clinical study of VALEDIA® before 31 July 2019

May 15^th, 2019

Diary

Clinical Innovation Day 2019

June 27^th, 2019

Partnering Day 2019

October 15^th, 2019

BIO International Convention 2019

June 3^th, 2019

Calls for projects

Eurostars calls

Before September 12^th, 2019

Draft topics for IMI2 – Calls 18 & 19 published

Continuous call

All calls for projects

Contact

Bâtiment Domilyon - 321, avenue Jean Jaurès - 69007 Lyon

Tel. : 04.72.76.53.30 - Fax : 09.55.91.30.26

info@lyonbiopole.com

By continuing to browse our site you agree to our use of cookies, revised Privacy Policy and Terms of Service. More information... Close